NO3034512T3 - - Google Patents

Info

Publication number
NO3034512T3
NO3034512T3 NO14386034A NO14386034A NO3034512T3 NO 3034512 T3 NO3034512 T3 NO 3034512T3 NO 14386034 A NO14386034 A NO 14386034A NO 14386034 A NO14386034 A NO 14386034A NO 3034512 T3 NO3034512 T3 NO 3034512T3
Authority
NO
Norway
Application number
NO14386034A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3034512T3 publication Critical patent/NO3034512T3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO14386034A 2014-12-19 2014-12-19 NO3034512T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14386034.4A EP3034512B1 (en) 2014-12-19 2014-12-19 A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NO3034512T3 true NO3034512T3 (cg-RX-API-DMAC10.html) 2018-05-05

Family

ID=52354737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14386034A NO3034512T3 (cg-RX-API-DMAC10.html) 2014-12-19 2014-12-19

Country Status (30)

Country Link
US (1) US20170340747A1 (cg-RX-API-DMAC10.html)
EP (1) EP3034512B1 (cg-RX-API-DMAC10.html)
AP (1) AP2017009801A0 (cg-RX-API-DMAC10.html)
AU (1) AU2015365885B2 (cg-RX-API-DMAC10.html)
BR (1) BR112017006621B1 (cg-RX-API-DMAC10.html)
CA (1) CA2959226C (cg-RX-API-DMAC10.html)
CL (1) CL2017001611A1 (cg-RX-API-DMAC10.html)
CO (1) CO2017003313A2 (cg-RX-API-DMAC10.html)
CY (1) CY1120037T1 (cg-RX-API-DMAC10.html)
DK (1) DK3034512T3 (cg-RX-API-DMAC10.html)
EA (1) EA031968B1 (cg-RX-API-DMAC10.html)
ES (1) ES2655238T3 (cg-RX-API-DMAC10.html)
GE (2) GEAP201914514A (cg-RX-API-DMAC10.html)
HR (1) HRP20171965T1 (cg-RX-API-DMAC10.html)
HU (1) HUE035302T2 (cg-RX-API-DMAC10.html)
IL (1) IL251449B (cg-RX-API-DMAC10.html)
LT (1) LT3034512T (cg-RX-API-DMAC10.html)
MX (1) MX374777B (cg-RX-API-DMAC10.html)
MY (1) MY185391A (cg-RX-API-DMAC10.html)
NO (1) NO3034512T3 (cg-RX-API-DMAC10.html)
PE (1) PE20180660A1 (cg-RX-API-DMAC10.html)
PH (1) PH12017500391B1 (cg-RX-API-DMAC10.html)
PL (1) PL3034512T3 (cg-RX-API-DMAC10.html)
PT (1) PT3034512T (cg-RX-API-DMAC10.html)
RS (1) RS56714B1 (cg-RX-API-DMAC10.html)
SA (1) SA517381261B1 (cg-RX-API-DMAC10.html)
SG (1) SG11201702593TA (cg-RX-API-DMAC10.html)
SI (1) SI3034512T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201800008T1 (cg-RX-API-DMAC10.html)
WO (1) WO2016096203A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009589B (el) 2018-04-05 2019-09-11 Ιουλια Κλεωνος Τσετη Φαρμακευτικο σκευασμα για την αντιμετωπιση της αναιμιας, σε καταλληλο περιεκτη, που διατηρει στεγανα διαχωρισμενα μεταξυ τους τα δραστικα συστατικα: συμπλοκο του τρισθενους σιδηρου με ν-ακετυλο-l-ασπαρτικη καζεϊνη και πενταϋδρικο φυλλινικο ασβεστιο
CN116655512A (zh) * 2023-05-31 2023-08-29 江苏阿尔法药业股份有限公司 一种卡托普利的制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB910321A (en) 1960-02-25 1962-11-14 Olivier Paul Gaudin Improvements in and relating to a process for preparing ferrous salts of aspartic acid and medicines containing these salts
IT1150213B (it) 1982-03-02 1986-12-10 Italfarmaco Spa Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche
IT1207996B (it) 1986-03-18 1989-06-01 Magis Farmaceutici Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
IT1297022B1 (it) 1997-12-24 1999-08-03 Chemi Spa Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono
ITMO20040200A1 (it) 2004-07-29 2004-10-29 Biofer Spa Processo per la produzione di complessi ferro succinilcaseina e ferro casein acetil aspartilato e loro utilizzato nelle relative composizioni farmaceutiche.

Also Published As

Publication number Publication date
CA2959226C (en) 2018-10-09
EA031968B1 (ru) 2019-03-29
RS56714B1 (sr) 2018-03-30
PT3034512T (pt) 2018-01-11
EP3034512A1 (en) 2016-06-22
SMT201800008T1 (it) 2018-03-08
HRP20171965T1 (hr) 2018-02-23
PE20180660A1 (es) 2018-04-17
CY1120037T1 (el) 2018-12-12
CL2017001611A1 (es) 2018-01-26
AU2015365885A1 (en) 2017-03-16
MY185391A (en) 2021-05-17
GEAP201914514A (en) 2019-10-25
IL251449A0 (en) 2017-05-29
PH12017500391A1 (en) 2017-07-17
EP3034512B1 (en) 2017-12-06
HUE035302T2 (en) 2018-05-02
MX374777B (es) 2025-03-06
EA201790902A1 (ru) 2017-10-31
SG11201702593TA (en) 2017-04-27
PH12017500391B1 (en) 2021-12-15
SI3034512T1 (en) 2018-04-30
SA517381261B1 (ar) 2017-12-20
WO2016096203A1 (en) 2016-06-23
ES2655238T3 (es) 2018-02-19
MX2017008100A (es) 2017-10-31
CA2959226A1 (en) 2016-06-23
IL251449B (en) 2019-02-28
DK3034512T3 (en) 2018-01-15
PL3034512T3 (pl) 2018-03-30
US20170340747A1 (en) 2017-11-30
CO2017003313A2 (es) 2017-07-28
AU2015365885B2 (en) 2018-11-15
BR112017006621B1 (pt) 2023-11-07
BR112017006621A2 (pt) 2017-12-19
LT3034512T (lt) 2018-01-25
GEP20207081B (en) 2020-03-25
AP2017009801A0 (en) 2017-03-31

Similar Documents

Publication Publication Date Title
BR112016017283A2 (cg-RX-API-DMAC10.html)
BR112016015519A2 (cg-RX-API-DMAC10.html)
BR112016015890A2 (cg-RX-API-DMAC10.html)
BR112016003131A2 (cg-RX-API-DMAC10.html)
BR112016015365A2 (cg-RX-API-DMAC10.html)
BR112016017303A2 (cg-RX-API-DMAC10.html)
BR112016016490A2 (cg-RX-API-DMAC10.html)
BR112016015605A2 (cg-RX-API-DMAC10.html)
BR112016016546A2 (cg-RX-API-DMAC10.html)
BR112016017103A2 (cg-RX-API-DMAC10.html)
BR112016015311A2 (cg-RX-API-DMAC10.html)
BR112016017031A2 (cg-RX-API-DMAC10.html)
BR112016016421A2 (cg-RX-API-DMAC10.html)
BR112016016106A2 (cg-RX-API-DMAC10.html)
BR112016012568A2 (cg-RX-API-DMAC10.html)
BR112016016558A2 (cg-RX-API-DMAC10.html)
BR112016015798A2 (cg-RX-API-DMAC10.html)
BR112016015915A2 (cg-RX-API-DMAC10.html)
BR112016017469A2 (cg-RX-API-DMAC10.html)
BR112016016468A2 (cg-RX-API-DMAC10.html)
BR112016017356A2 (cg-RX-API-DMAC10.html)
BR112016017551A2 (cg-RX-API-DMAC10.html)
BR112016016459A2 (cg-RX-API-DMAC10.html)
BR112016003522A2 (cg-RX-API-DMAC10.html)
BR112016017221A2 (cg-RX-API-DMAC10.html)